Research output per year
Research output per year
Personal profile
Expertises
Specialist in Endocrinology and Internal Medicine.
Large experience within the field of diabetes with focus on pregnant women with diabetes.
Main research areas
Pregnant women with type 1 diabetes
Pregnant women with type 2 diabetes
Gestational diabetes
Implications of gestational diabetes for the health of mother and child in the long run
Excessive fetal growth, preeclampsia and preterm birth
Diabetic nephropathy
Diabetes after pancreaectomi
Cystic fibrosis related diabetes
Current research
The role of glycemic control, gestational weight gain and appropriate blood pressure control for pregnancy outcome in women with type 1 diabetes, type 2 diabetes and gestational diabetes.
Focus on pregnancy complications as fetal overgrowth, pregnancy induced hypertensive disorders and preterm birth.
Focus on treatment modalities as diet, physical activity, insulin analogues, insulin pump, continous glucose monitoring, enhancing motivations in the patients and blood pressure control.
Potential conflicts of interest
Recieve speaker fee from Novonordisk , Astra Zeneca, Lily and Aventis.
Participate in advisory group meetings for Novonordisk.
Fingerprint
Dive into the research topics where Elisabeth Reinhardt Mathiesen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Congenital malformations among offspring of women with type 1 diabetes who use insulin pumps: a prospective cohort study
Thorius, I. H., Husemoen, L. L. N., Nordsborg, R. B., Alibegovic, A. C., Gall, M-A., Petersen, J. & Mathiesen, E. R., May 2023, In: Diabetologia. 66, 5, p. 826-836 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open‑label, multinational, randomised, controlled, non-inferiority trial
Mathiesen, E. R., Alibegovic, A. C., Corcoy, R., Dunne, F., Feig, D. S., Hod, M., Jia, T., Kalyanam, B., Kar, S., Kautzky-Willer, A., Marchesini, C., Rea, R. D., Damm, P. & EXPECT study group, Feb 2023, In: The Lancet Diabetes and Endocrinology. 11, 2, p. 86-95 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Is the Biphasic Effect of Diabetes and Obesity on Fetal Growth a Risk Factor for Childhood Obesity?
van Poppel, M. N. M., Damm, P., Mathiesen, E. R., Ringholm, L., Zhang, C. & Desoye, G., 1 Jun 2023, In: Diabetes Care. 46, 6, p. 1124-1131 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Major congenital malformations in offspring of women with chronic diseases-impact of the disease or the treatment?
Demir, L. Ü., Mathiesen, E. R., Damm, P. & Ringholm, L., Feb 2023, In: AJOG global reports. 3, 1, p. 100153 100153.Research output: Contribution to journal › Journal article › Research › peer-review
-
Pregnancy outcomes in women with type 1 diabetes using insulin degludec: response to Kamran et al
Ringholm, L., Do, N. C., Damm, P. & Mathiesen, E. R., 2023, In: Acta Diabetologica. 60, 1, p. 141-142 2 p.Research output: Contribution to journal › Letter › peer-review